Antibiotics-BaselPub Date : 2024-10-18DOI: 10.3390/antibiotics13100985
Lucia Recinella, Morena Pinti, Maria Loreta Libero, Silvia Di Lodovico, Serena Veschi, Anna Piro, Daniele Generali, Alessandra Acquaviva, Nilofar Nilofar, Giustino Orlando, Annalisa Chiavaroli, Claudio Ferrante, Luigi Menghini, Simonetta Cristina Di Simone, Luigi Brunetti, Mara Di Giulio, Sheila Leone
{"title":"Beneficial Effects Induced by a Proprietary Blend of a New Bromelain-Based Polyenzymatic Complex Plus N-Acetylcysteine in Urinary Tract Infections: Results from In Vitro and Ex Vivo Studies.","authors":"Lucia Recinella, Morena Pinti, Maria Loreta Libero, Silvia Di Lodovico, Serena Veschi, Anna Piro, Daniele Generali, Alessandra Acquaviva, Nilofar Nilofar, Giustino Orlando, Annalisa Chiavaroli, Claudio Ferrante, Luigi Menghini, Simonetta Cristina Di Simone, Luigi Brunetti, Mara Di Giulio, Sheila Leone","doi":"10.3390/antibiotics13100985","DOIUrl":"https://doi.org/10.3390/antibiotics13100985","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Urinary tract infections (UTIs) are infections that involve the urethra, bladder, and, in much more severe cases, even kidneys. These infections represent one of the most common diseases worldwide. Various pathogens are responsible for this condition, the most common being <i>Escherichia coli</i> (<i>E. coli</i>). Bromelain is a proteolytic complex obtained from the stem and stalk of <i>Ananas comosus</i> (L.) Merr. showing several beneficial activities. In addition to bromelain, N-acetylcysteine (NAC) has also been used. <b>Methods:</b> The purpose of this experiment was to evaluate the antibacterial, anti-motility, and anti-biofilm effects of a new polyenzymatic complex (DIF17BRO<sup>®</sup>) in combination with NAC (the Formulation) on various strains of <i>E. coli</i> isolated from patients with UTIs. Subsequently, the anti-inflammatory and antioxidant effects of the Formulation were studied in an ex vivo model of cystitis, using bladder samples from mice exposed to <i>E. coli</i> lipopolysaccharide (LPS). <b>Results:</b> Our results showed that the Formulation significantly affects the capability of bacteria to form biofilm and reduces the bacteria amount in the mature biofilm. Moreover, it combines the interesting properties of NAC and a polyenzyme plant complex based on bromelain in a right dose to affect the <i>E. coli</i> adhesion capability. Finally, the Formulation exhibited protective effects, as confirmed by the inhibitory activities on multiple inflammatory and oxidative stress-related pathways on bladder specimens exposed to LPS. <b>Conclusions:</b> This blend of active compounds could represent a promising and versatile approach to use to overcome the limitations associated with conventional therapies.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antibiotics-BaselPub Date : 2024-10-18DOI: 10.3390/antibiotics13100988
Martina Buttera, Lucia Corso, Leonardo Casadei, Cinzia Valenza, Francesca Sforza, Francesco Candia, Francesca Miselli, Cecilia Baraldi, Licia Lugli, Alberto Berardi, Lorenzo Iughetti
{"title":"Can a Shorter Dwell Time Reduce Infective Complications Associated with the Use of Umbilical Catheters?","authors":"Martina Buttera, Lucia Corso, Leonardo Casadei, Cinzia Valenza, Francesca Sforza, Francesco Candia, Francesca Miselli, Cecilia Baraldi, Licia Lugli, Alberto Berardi, Lorenzo Iughetti","doi":"10.3390/antibiotics13100988","DOIUrl":"https://doi.org/10.3390/antibiotics13100988","url":null,"abstract":"<p><strong>Background: </strong>Umbilical venous catheters (UVCs) are the standard of care in neonatal intensive care units (NICUs) to administer fluids, parenteral nutrition and medications, although complications may occur, including central line-associated blood stream infections (CLABSIs). However, the dwell time to reduce CLABSI risk remains an open issue.</p><p><strong>Methods: </strong>We performed a single-center retrospective study of newborns hospitalized in the Modena NICU with at least one UVC inserted over a 6-year period (period 1: January 2011-December 2013; period 2: January 2019-December 2021). We selected a non-consecutive 6-year period to emphasize the differences in UVC management practices that have occurred over time in our NICU. The UVC dwell time and catheter-related complications during the first 4 weeks of life were examined.</p><p><strong>Results: </strong>The UVC dwell time was shorter in period 2 (median 4 days vs. 5 days, <i>p</i> < 0.00001). Between the two periods, the incidence of CLABSIs remained unchanged (<i>p =</i> 0.5425). However, in period 2, there was an increased need for peripherally inserted central catheters (PICCs) after UVC removal, with a rise in PICC infections after UVC removal (<i>p =</i> 0.0239).</p><p><strong>Conclusions: </strong>In our NICU, shortening UVC dwell time from 5 to 4 days did not decrease the UVC-related complications. Instead, the earlier removal of UVCs led to a higher number of PICCs inserted, possibly increasing the overall infectious risk.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antibiotics-BaselPub Date : 2024-10-18DOI: 10.3390/antibiotics13100987
Laura Maria De Plano, Manuela Caratozzolo, Sabrina Conoci, Salvatore P P Guglielmino, Domenico Franco
{"title":"Impact of Nutrient Starvation on Biofilm Formation in <i>Pseudomonas aeruginosa</i>: An Analysis of Growth, Adhesion, and Spatial Distribution.","authors":"Laura Maria De Plano, Manuela Caratozzolo, Sabrina Conoci, Salvatore P P Guglielmino, Domenico Franco","doi":"10.3390/antibiotics13100987","DOIUrl":"https://doi.org/10.3390/antibiotics13100987","url":null,"abstract":"<p><p><b>Objectives:</b> This study investigates the impact of nutrient availability on the growth, adhesion, and biofilm formation of <i>Pseudomonas aeruginosa</i> ATCC 27853 under static conditions. <b>Methods:</b> Bacterial behaviour was evaluated in nutrient-rich Luria-Bertani (LB) broth and nutrient-limited M9 media, specifically lacking carbon (M9-C), nitrogen (M9-N), or phosphorus (M9-P). Bacterial adhesion was analysed microscopically during the transition from reversible to irreversible attachment (up to 120 min) and during biofilm production/maturation stages (up to 72 h). <b>Results:</b> Results demonstrated that LB and M9 media supported bacterial growth, whereas nutrient-starved conditions halted growth, with M9-C and M9-N inducing stationary phases and M9-P leading to cell death. Fractal analysis was employed to characterise the spatial distribution and complexity of bacterial adhesion patterns, revealing that nutrient-limited conditions affected both adhesion density and biofilm architecture, particularly in M9-C. In addition, live/dead staining confirmed a higher proportion of dead cells in M9-P over time (at 48 and 72 h). <b>Conclusions</b>: This study highlights how nutrient starvation influences biofilm formation and bacterial dispersion, offering insights into the survival strategies of <i>P. aeruginosa</i> in resource-limited environments. These findings should contribute to a better understanding of biofilm dynamics, with implications for managing biofilm-related infections and industrial biofouling.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antibiotics-BaselPub Date : 2024-10-17DOI: 10.3390/antibiotics13100978
Michal Piotrowski, Irina Alekseeva, Urs Arnet, Emre Yücel
{"title":"Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and <i>Pseudomonas aeruginosa</i> Epidemic Infections in Eastern Europe: A Systematic Literature Review.","authors":"Michal Piotrowski, Irina Alekseeva, Urs Arnet, Emre Yücel","doi":"10.3390/antibiotics13100978","DOIUrl":"https://doi.org/10.3390/antibiotics13100978","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance is a major global public health challenge, particularly with the rise of carbapenem-resistant Enterobacterales (CRE) and <i>Pseudomonas aeruginosa</i> (CRPA). This study aimed to describe the characteristics of CRE and CRPA infections in Eastern Europe, focusing on Bulgaria, Croatia, Czechia, Greece, Hungary, Poland, Romania, Serbia, Slovakia, and Slovenia.</p><p><strong>Methods: </strong>Following MOOSE and PRISMA guidelines, a systematic literature review of articles published between 1 November 2017 and 1 November 2023 was conducted using the MEDLINE, Embase, Web of Science, CDSR, DARE, and CENTRAL databases. The search strategy used a combination of free text and subject headings to gather pertinent literature regarding the incidence and treatment patterns of CRE and CRPA infections. A total of 104 studies focusing on infections in both children and adults were included in this review.</p><p><strong>Results: </strong>This review revealed a significant prevalence of carbapenem-resistant Gram-negative isolates and underscored the effectiveness of imipenem/relebactam and ceftazidime/avibactam (CAZ/AVI) against Klebsiella pneumoniae carbapenemase-producing Enterobacterales and of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against non-metallo-β-lactamase-producing CRPA strains.</p><p><strong>Conclusions: </strong>This study highlights the urgent need for comprehensive measures to combat the escalating threat of CRE and CRPA infections in Eastern European countries. At the same time, it shows the activity of the standard of care and new antimicrobials against carbapenem-resistant Gram-negative pathogens in Eastern Europe. Clinical real-world data on the treatment of carbapenem-resistant infections in Eastern Europe are needed.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antibiotics-BaselPub Date : 2024-10-17DOI: 10.3390/antibiotics13100982
Nina Kassner, Meinolf Wonnemann, Yvonne Ziegler, Rainer Stange, Karel Kostev
{"title":"Investigation into the Effectiveness of an Herbal Combination (Angocin<sup>®</sup><i>Anti-Infekt N</i>) in the Therapy of Acute Bronchitis: A Retrospective Real-World Cohort Study.","authors":"Nina Kassner, Meinolf Wonnemann, Yvonne Ziegler, Rainer Stange, Karel Kostev","doi":"10.3390/antibiotics13100982","DOIUrl":"https://doi.org/10.3390/antibiotics13100982","url":null,"abstract":"<p><strong>Background: </strong>The goal of this study was to evaluate whether the medical recommendation of Angocin<sup>®</sup><i>Anti-Infekt N</i> (heretofore referenced as Angocin<sup>®</sup>) on the day of diagnosis of acute bronchitis is negatively associated with the recurrence of acute bronchitis diagnosis, antibiotic prescriptions, incidence of chronic bronchitis, and duration of sick leave.</p><p><strong>Methods: </strong>This study included patients in general practices in Germany with a first documented diagnosis of acute bronchitis between 2005 and 2022 (index date) and a prescription of Angocin<sup>®</sup>, thyme products, essential oils, mucolytics or antibiotics on the index date. The association between Angocin<sup>®</sup> prescription and the risks of a relapse of acute bronchitis, development of chronic bronchitis, or subsequent antibiotic prescription were evaluated using Cox regression models. Univariable conditional logistic regression models were used to investigate the association between Angocin<sup>®</sup> prescription and duration of sick leave.</p><p><strong>Results: </strong>After a 1:5 propensity score matching, 598 Angocin<sup>®</sup> patients and 2990 patients in each of the four comparison cohorts were available for analysis. Angocin<sup>®</sup> prescription was associated with significantly lower incidence of a renewed confirmed diagnosis of acute bronchitis as compared to essential oils (Hazard ratio (HR): 0.61; 95% Confidence Interval (CI): 0.46-0.80), thyme products (HR: 0.70; 95% CI: 0.53-0.91), mucolytics (HR: 0.65; 95% CI: 0.49-0.85) or antibiotics (HR: 0.64; 95% CI: 0.49-0.84). Also, there were significantly lower incidences of subsequent re-prescriptions of antibiotics when compared to mucolytics (HR: 0.73; 95% CI: 0.53-0.99) or antibiotics (HR: 0.53; 95% CI: 0.39-0.72) and a significantly lower risk of chronic bronchitis as compared to essential oils (HR: 0.60; 95% CI: 0.46-0.78), thyme products (HR: 0.53; 95% CI: 0.41-0.69), mucolytics (HR: 0.49; 95% CI: 0.38-0.63) or antibiotics (HR: 0.59; 95% CI: 0.45-0.76).</p><p><strong>Conclusions: </strong>Considering the limitations of the study, the results shed light on the sustaining effectiveness of Angocin<sup>®</sup> prescription in the management of acute bronchitis and the associated outcomes when compared to several other treatments commonly used for this condition.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Validation of Recombinase Polymerase Amplification with In-House Lateral Flow Assay for <i>mcr-1</i> Gene Detection of Colistin Resistant <i>Escherichia coli</i> Isolates.","authors":"Naeem Ullah, Nutchaba Suchanta, Umaporn Pimpitak, Pitak Santanirand, Nutthee Am-In, Nuntaree Chaichanawongsaroj","doi":"10.3390/antibiotics13100984","DOIUrl":"https://doi.org/10.3390/antibiotics13100984","url":null,"abstract":"<p><strong>Background/objectives: </strong>The emergence of the mobilized colistin resistance 1 (<i>mcr-1</i>) gene, which causes colistin resistance, is a serious concern in animal husbandry, particularly in pigs. Although antibiotic regulations in many countries have prohibited the use of colistin in livestock, the persistence and dissemination of this plasmid-mediated gene require effective and rapid monitoring. Therefore, a rapid, sensitive, and specific method combining recombinase polymerase amplification (RPA) with an in-house lateral flow assay (LFA) for the <i>mcr-1</i> gene detection was developed.</p><p><strong>Methods: </strong>The colistin agar test and broth microdilution were employed to screen 152 <i>E. coli</i> isolates from pig fecal samples of five antibiotic-used farms. The established RPA-in-house LFA was validated with PCR for <i>mcr-1</i> gene detection.</p><p><strong>Results: </strong>The RPA-in-house LFA was completed within 35 min (20 min of amplification and 5-15 min on LFA detection) at 37 °C. The sensitivity, specificity, and accuracy were entirely 100% in concordance with PCR results. No cross-reactivity was detected with seven common pathogenic bacteria or other <i>mcr</i> gene variants.</p><p><strong>Conclusions: </strong>Therefore, the in-house RPA-LFA serves as a point-of-care testing tool that is rapid, simple, and portable, facilitating effective surveillance of colistin resistance in both veterinary and clinical settings, thereby enhancing health outcomes.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antibiotics-BaselPub Date : 2024-10-17DOI: 10.3390/antibiotics13100980
Vladimir S Kurćubić, Vesna Đurović, Slaviša B Stajić, Marko Dmitrić, Saša Živković, Luka V Kurćubić, Pavle Z Mašković, Jelena Mašković, Milan Mitić, Vladimir Živković, Vladimir Jakovljević
{"title":"Multitarget Phytocomplex: Focus on Antibacterial Profiles of Grape Pomace and <i>Sambucus ebulus</i> L. Lyophilisates Against Extensively Drug-Resistant (XDR) Bacteria and In Vitro Antioxidative Power.","authors":"Vladimir S Kurćubić, Vesna Đurović, Slaviša B Stajić, Marko Dmitrić, Saša Živković, Luka V Kurćubić, Pavle Z Mašković, Jelena Mašković, Milan Mitić, Vladimir Živković, Vladimir Jakovljević","doi":"10.3390/antibiotics13100980","DOIUrl":"https://doi.org/10.3390/antibiotics13100980","url":null,"abstract":"<p><p><b>Objectives:</b> This study was conceived with the aim of translating the experience and knowledge of the research group into the design and creation of multi-active phytocomplex cocktails from lyophilised winery by-products (Grape Pomace-GP) and weeds (<i>Sambucus ebulus</i> L., Dwarf Elder-DE). <b>Methods:</b> Quantification of bioactive molecules was performed by high-performance liquid chromatography (HPLC) method. <b>Results:</b> In the extract obtained from lyophilised GP, the most dominant component that was quantified was petunidin-3-glucoside. Prominent compounds that were quantified in DE extract were cyanidin derivatives. The total number of microorganisms in lyophilisates is low, but some of them still survive lyophilisation. Antibacterial activity was determined by microdilution, the minimum inhibitory concentration (MIC) of the tested bacteria ranged from 0.78 mg/mL to 25.00 mg/mL. Antibacterial susceptibility testing (AST) revealed that <i>Klebsiella</i> spp. and <i>Acinetobacter baumannii</i> complex are extensively drug-resistant (XDR). <b>Conclusions:</b> The GP + DE cocktail showed very strong AB power against both tested XDR bacteria. The total phenolic content and antioxidative effect (determined spectrophotometrically) indicate their linear correlation.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antibiotics-BaselPub Date : 2024-10-17DOI: 10.3390/antibiotics13100983
Yan Corrêa Rodrigues, Marcos Jessé Abrahão Silva, Herald Souza Dos Reis, Pabllo Antonny Silva Dos Santos, Daniele Melo Sardinha, Maria Isabel Montoril Gouveia, Carolynne Silva Dos Santos, Davi Josué Marcon, Caio Augusto Martins Aires, Cintya de Oliveira Souza, Ana Judith Pires Garcia Quaresma, Luana Nepomuceno Gondim Costa Lima, Danielle Murici Brasiliense, Karla Valéria Batista Lima
{"title":"Molecular Epidemiology of <i>Pseudomonas aeruginosa</i> in Brazil: A Systematic Review and Meta-Analysis.","authors":"Yan Corrêa Rodrigues, Marcos Jessé Abrahão Silva, Herald Souza Dos Reis, Pabllo Antonny Silva Dos Santos, Daniele Melo Sardinha, Maria Isabel Montoril Gouveia, Carolynne Silva Dos Santos, Davi Josué Marcon, Caio Augusto Martins Aires, Cintya de Oliveira Souza, Ana Judith Pires Garcia Quaresma, Luana Nepomuceno Gondim Costa Lima, Danielle Murici Brasiliense, Karla Valéria Batista Lima","doi":"10.3390/antibiotics13100983","DOIUrl":"https://doi.org/10.3390/antibiotics13100983","url":null,"abstract":"<p><strong>Background: </strong>Globally, <i>Pseudomonas aeruginosa</i> is a high-priority opportunistic pathogen which displays several intrinsic and acquired antimicrobial resistance (AMR) mechanisms, leading to challenging treatments and mortality of patients. Moreover, its wide virulence arsenal, particularly the type III secretion system (T3SS) <i>exoU<sup>+</sup></i> virulotype, plays a crucial role in pathogenicity and poor outcome of infections. In depth insights into the molecular epidemiology of <i>P. aeruginosa</i>, especially the prevalence of high-risk clones (HRCs), are crucial for the comprehension of virulence and AMR features and their dissemination among distinct strains. This study aims to evaluate the prevalence and distribution of HRCs and non-HRCs among Brazilian isolates of <i>P. aeruginosa</i>.</p><p><strong>Methods: </strong>A systematic review and meta-analysis were conducted on studies published between 2011 and 2023, focusing on the prevalence of <i>P. aeruginosa</i> clones determined by multilocus sequence typing (MLST) in Brazil. Data were extracted from retrospective cross-sectional and case-control studies, encompassing clinical and non-clinical samples. The analysis included calculating the prevalence rates of various sequence types (STs) and assessing the regional variability in the distribution of HRCs and non-HRCs.</p><p><strong>Results: </strong>A total of 872 samples were analyzed within all studies, of which 298 (34.17%) were MLST typed, identifying 78 unique STs. HRCs accounted for 48.90% of the MLST-typed isolates, with ST277 being the most prevalent (100/298-33.55%), followed by ST244 (29/298-9.73%), ST235 (13/298-4.36%), ST111 (2/298-0.67%), and ST357 (2/298-0.67%). Significant regional variability was observed, with the Southeast region showing a high prevalence of ST277, while the North region shows a high prevalence of MLST-typed samples and HRCs.</p><p><strong>Conclusions: </strong>Finally, this systematic review and meta-analysis highlight the role of <i>P. aeruginosa</i> clones in critical issue of AMR in <i>P. aeruginosa</i> in Brazil and the need of integration of comprehensive data from individual studies.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antibiotics-BaselPub Date : 2024-10-17DOI: 10.3390/antibiotics13100979
Eric G Romanowski, Jonathan B Mandell, Vishal Jhanji, Robert M Q Shanks
{"title":"The Efficacy of Topical Cefiderocol Treatment of Experimental Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Keratitis Is Dependent upon the State of the Corneal Epithelium.","authors":"Eric G Romanowski, Jonathan B Mandell, Vishal Jhanji, Robert M Q Shanks","doi":"10.3390/antibiotics13100979","DOIUrl":"10.3390/antibiotics13100979","url":null,"abstract":"<p><p><b>Background:</b> An overlooked factor in the efficacy of topical antibiotics to treat bacterial keratitis is the state of the corneal epithelium. Recently, we evaluated topical cefiderocol for the treatment of extensively drug-resistant (XDR) <i>Pseudomonas aeruginosa</i> (PA) keratitis in eyes with the corneal epithelium abraded. The goal of this study was to use the same model with the corneal epithelium left intact to evaluate the efficacy of cefiderocol and other antibiotics and compare the results to those of the previous study. <b>Methods:</b> NZW rabbit corneas with intact epithelium were inoculated with XDRPA. After 16 h, the rabbits were topically treated with cefiderocol 50 mg/mL, ciprofloxacin 0.3%, tobramycin 14 mg/mL, or saline. Following 8 h of treatment, the corneas were harvested for CFU determinations and cefiderocol concentrations. <b>Results:</b> Only cefiderocol significantly decreased CFU of the XDRPA strain compared with saline. The CFU in the cefiderocol and tobramycin-treated corneas for the XDRPA strain with initially intact epithelium were 1.83-1.4 Log<sub>10</sub> greater than those produced in corneas with the abraded epithelium (<i>p</i> < 0.05). Cefiderocol concentrations were 5.02× less in corneas with initially intact epithelium. <b>Conclusions:</b> The efficacy of cefiderocol and tobramycin to treat experimental XDRPA keratitis is dependent on the state of the corneal epithelium.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Point-Prevalence Survey of Antimicrobial Use and Healthcare-Associated Infections in Four Acute Care Hospitals in Kazakhstan.","authors":"Yuliya Semenova, Aizhan Yessmagambetova, Zaure Akhmetova, Manar Smagul, Akniyet Zharylkassynova, Bibigul Aubakirova, Kateryna Soiak, Zhanar Kosherova, Ainur Aimurziyeva, Larissa Makalkina, Ainur Ikhambayeva, Lisa Lim","doi":"10.3390/antibiotics13100981","DOIUrl":"https://doi.org/10.3390/antibiotics13100981","url":null,"abstract":"<p><strong>Background/objectives: </strong>Few studies have examined the prevalence of healthcare-associated infections (HAIs) and antimicrobial use (AMU) in acute care hospitals in Kazakhstan. This study aimed to address this gap by conducting a point-prevalence survey (PPS) of HAIs and AMU, as well as evaluating hospital antibiotic consumption via internationally recognized methodologies.</p><p><strong>Methods: </strong>PPS was conducted in four acute care hospitals in Kazakhstan on 11 May 2022, following the methodology of the European Center for Disease Prevention and Control, and included 701 patients. Antibiotic consumption in the same hospitals was assessed via the Global Antimicrobial Resistance and Use Surveillance System methodology.</p><p><strong>Results: </strong>HAIs were observed in 3.8% of patients (27/701), with intensive care unit wards accounting for 48.1% of these cases (13/27). <i>Pseudomonas aeruginosa</i> was the most frequently identified pathogen (5 out of 14 documented cases, 35.7%). Resistance to carbapenems was the most common resistance, followed by resistance to glycopeptides and third-generation cephalosporins. The rate of AMU was 38.2%, with an average of 1.37 antibiotics administered per patient. Surgical prophylaxis lasting more than one day was the most common indication for antimicrobial prescription (44.8%). Ceftriaxone and cefazolin are the most commonly used antibiotics.</p><p><strong>Conclusions: </strong>The results of this study are important for understanding the current situation in Kazakhstan and for informing national antimicrobial stewardship and infection control strategies.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}